Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models

ConclusionsCYP isoforms along with fungal incubation results were in good agreement to those obtained with pHLM incubation. CYP2E1 was responsible for many of the metabolic pathways; particularly for PX-1. This study shows that all three in vitro assays are suitable for predicting metabolic pathways of synthetic cannabinoids. To establish completeness of the PX-1 and PX-2 metabolic pathways, it is not only recommended but also necessary to use different assays.
Source: Forensic Toxicology - Category: Forensic Medicine Source Type: research